Cargando…
TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
Objective: The aim of this study was to measure both plasma and cerebrospinal fluid (CSF) TAR DNA-binding protein 43 (TDP-43) and phosphorylated TDP-43 (pTDP-43) levels in sporadic amyotrophic lateral sclerosis (sALS) patients, and to compare them with that of healthy controls. The correlation betwe...
Autores principales: | Ren, Yuting, Li, Siyuan, Chen, Siyu, Sun, Xiaosun, Yang, Fei, Wang, Hongfen, Li, Mao, Cui, Fang, Huang, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236522/ https://www.ncbi.nlm.nih.gov/pubmed/34194383 http://dx.doi.org/10.3389/fneur.2021.663637 |
Ejemplares similares
-
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF
por: Audrain, Mickael, et al.
Publicado: (2023) -
Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018) -
Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)